BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6100064)

  • 21. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 22. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.
    Gershon AA; Steinberg SP; Gelb L; Galasso G; Borkowsky W; LaRussa P; Farrara A
    JAMA; 1984 Jul; 252(3):355-62. PubMed ID: 6330386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of varicella vaccine for healthy children.
    Starr SE
    Pediatrics; 1989 Dec; 84(6):1097-9. PubMed ID: 2555765
    [No Abstract]   [Full Text] [Related]  

  • 27. Licensure of Varicella Virus Vaccine, Live.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Apr; 44(13):264. PubMed ID: 7898423
    [No Abstract]   [Full Text] [Related]  

  • 28. Varicella vaccine guidelines.
    DiNicola AF
    Pediatrics; 1995 Aug; 96(2 Pt 1):375-6. PubMed ID: 7630706
    [No Abstract]   [Full Text] [Related]  

  • 29. Human immune responses to live attenuated varicella vaccine.
    Gershon AA
    Rev Infect Dis; 1991; 13 Suppl 11():S957-9. PubMed ID: 1664134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella vaccine: decisions a little nearer.
    McIntosh K
    N Engl J Med; 1984 May; 310(22):1456-7. PubMed ID: 6325911
    [No Abstract]   [Full Text] [Related]  

  • 31. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine.
    Watson B; Boardman C; Laufer D; Piercy S; Tustin N; Olaleye D; Cnaan A; Starr SE
    Clin Infect Dis; 1995 Feb; 20(2):316-9. PubMed ID: 7742436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a live varicella vaccine for acute leukemic children shortly after exposure in a children's ward.
    Ozaki T; Nagayoshi S; Morishima T; Isomura S; Suzuki S; Asano Y; Takahashi M
    Biken J; 1978 Jun; 21(2):69-72. PubMed ID: 219841
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.
    Nunoue T
    Biken J; 1984 Sep; 27(2-3):115-8. PubMed ID: 6100047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella infection in a children's hospital: prevention by vaccine and an episode of airborne transmission.
    Tsujino G; Sako M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):129-32. PubMed ID: 6100050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary study of an attenuated varicella-zoster vaccine (Webster strain) in 27 children without immunologic disorders].
    Hediard B; Burguiere AM; Devillechabrolle A; Lemerle S; Reinert P; Plotkin SA; Huraux JM
    Ann Pediatr (Paris); 1983 Jun; 30(6):440-4. PubMed ID: 6309063
    [No Abstract]   [Full Text] [Related]  

  • 37. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination against varicella].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):321-4. PubMed ID: 7491430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trial of a varicella vaccine in 100 high-risk children].
    Vialatte J; Broyer M; Griscelli C; Gaiffe M; Badillet M; Georges AM
    Dev Biol Stand; 1982; 52():385-90. PubMed ID: 6299848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.